market access

Market Access

Leveraging KOL insights to succeed in a data-driven world

For years, key opinion leaders (KOLs) have held a position of authority and respect amongst those working across the life science industry, be it a result of their expertise in a specific t

News

Equity_World_Access_Map_1140x675_CountryList

Pfizer makes non-profit pledge for low-income nations

US pharma giant Pfizer has said it will sell some of its patented medicines at non-profit prices to 45 of the world's poorest countries – including new launches.

News

NICE finds solution to making Keytruda available for TNBC

Around 100 patients in England and Wales with triple negative breast cancer (TNBC) that has spread to other parts of the body could soon access treatment with Merck & Co/MSD's Keytruda,

Market Access

Rethinking value: why diverse viewpoints matter

Value is a tricky concept to capture accurately.

Market Access

Deep Dive: Market Access

For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated challenge.

News

Closeup of X-ray photography of human brain

Biogen pulls EU application for Alzheimer's drug Aduhelm

Biogen has given up on seeking approval for its Alzheimer's disease therapy Aduhelm in the EU, saying that discussions with EU regulators had made it clear the current data for the drug is

Leveraging KOL insights to succeed in a data-driven world

Pfizer makes non-profit pledge for low-income nations

NICE finds solution to making Keytruda available for TNBC

Rethinking value: why diverse viewpoints matter

Deep Dive: Market Access

Biogen pulls EU application for Alzheimer's drug Aduhelm

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks